A multivariate regression analysis confirmed a significant association between group affiliation and changes in fetuin-B levels, indicating that metformin therapy played a key role in modulating this marker in PCOS patients (B: 1.80; 95% CIs: 0.57–3.03; p = 0.01). The gene discussed is FETUB; the disease is polycystic ovary syndrome.